GlassScriptPhysician profile
Judith Prairie
NPI 1407352255
$4,120.27
in general payments reported to CMS, 2019-2025
28 companies · $1,821 in 2025
The $1,821 reported for 2025 was more than what 94% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $105 · 2022: $519 · 2023: $785 · 2024: $890 · 2025: $1,821.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,414 · Education: $82.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,414.01 |
| Education | $82.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,015.69 | 2021-2025 | Wegovy, Rybelsus, Ozempic |
| Abbvie INC. | $671.52 | 2022-2025 | Vraylar, Ubrelvy |
| Amgen INC. | $455.86 | 2022-2025 | Evenity, Prolia, Otezla |
| Lilly USA, LLC | $280.65 | 2022-2025 | Mounjaro, Zepbound, Jardiance |
| Pfizer INC. | $261.09 | 2023-2025 | |
| Astrazeneca Pharmaceuticals LP | $216.22 | 2023-2025 | Farxiga, Airsupra |
| Axsome Therapeutics, INC. | $203.68 | 2024-2025 | Auvelity |
| Currax Pharmaceuticals LLC | $201.95 | 2023-2024 | Contrave, Nexletol, Onzetra Xsail |
| Bayer Healthcare Pharmaceuticals INC. | $125.46 | 2023-2025 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $98.71 | 2024-2025 | Caplyta |
| Boehringer Ingelheim Pharmaceuticals, INC. | $66.84 | 2023-2025 | Synjardy, Jardiance |
| Atland Pharmaceuticals, LLC | $60.01 | 2025 | Orphenadrine Citrate, Aspirin and Caffeine, Tolmetin Sodium |
| Almatica Pharma LLC | $55.19 | 2022 | |
| Vbi Vaccine (Delaware) INC. | $52.16 | 2022-2023 | Prehevbrio |
| Glaxosmithkline, LLC. | $51.64 | 2024-2025 | Trelegy Ellipta |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $50.43 | 2023-2025 | Cologuard Collection Kit |
| Abbott Laboratories | $42.21 | 2025 | Freestyle Libre 3 |
| Otsuka America Pharmaceutical, INC. | $24.07 | 2025 | Rexulti |
| Corcept Therapeutics | $23.55 | 2025 | Korlym |
| Baxter Healthcare | $21.88 | 2024 | Hillrom - Retinavue 700 Imager |
| Cranial Technologies, INC | $19.69 | 2025 | Doc Band |
| Abiomed | $19.39 | 2025 | |
| Sumitomo Pharma America, INC. | $18.88 | 2025 | Gemtesa |
| Merck Sharp & Dohme LLC | $18.48 | 2025 | Capvaxive |
| Irhythm Technologies, INC. | $18.01 | 2024 | Zio Monitor, Zio Xt Patch |
| Medtronic, INC. | $17.97 | 2024 | Venaseal |
| Vanda Pharmaceuticals INC. | $14.73 | 2025 | Fanapt |
| Phathom Pharmaceuticals, INC. | $14.31 | 2025 | Voquezna |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Judith Prairie listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.